Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC5R | P33032 | 1/20 | 0.66 |
| ▸ | MC3R | P41968 | 1/20 | 0.66 |
| ▸ | MC1R | Q01726 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 5/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | HTR2A | P28223 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | G6PD | P11413 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.60 |
| ▸ | AANAT | Q16613 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489675 | 1.00 | MC5R (0.66) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL5939865 | 0.90 | MC5R (0.64) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL3427633 | 0.87 | MC5R (0.64) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL29874992 | 0.85 | MC1R (0.60) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL250139 | 0.85 | MC1R (0.60) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL9542634 | 0.85 | HTR2A (0.63) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL7037221 | 0.84 | MC5R (0.73) | MC5RMC3RMC1RKMT2AMEN1 | |
| SCHEMBL17232881 | 0.84 | MC5R (0.83) | MC5RMC3RMC1RKMT2AMEN1 | |
| Indolylpropionic Acid SCHEMBL29521227 | 0.83 | MAPT (0.68) | KMT2AMEN1NPC1RAB9AHTR2A | |
| Indolylpropionic Acid SCHEMBL195405 | 0.83 | MAPT (0.68) | KMT2AMEN1NPC1RAB9AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589171-B2 | 177-Lu labeled peptide for site-specific uPAR-targeting | TRT INNOVATIONS APS (DK) | 2026-03-31 | — | — | US | claimed |
| EP-4448020-B1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | CURASIGHT AS (DK) | 2026-02-04 | — | — | EP | claimed |
| EP-4678194-A1 | THERAPEUTIC APPLICATION OF 64CU-LABELLED CONJUGATES FOR SITE-SPECIFIC UPAR-TARGETING | Curasight A/S (DK) | 2026-01-14 | — | — | EP | claimed |
| EP-4651912-A1 | RADIONUCLIDE LABELLED PEPTIDE CONJUGATE FOR SITE-SPECIFIC UPAR-TARGETING | Curasight A/S (DK) | 2025-11-26 | — | — | EP | claimed |
| US-20250319215-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCCS) | CURASIGHT AS (DK) | 2025-10-16 | — | — | US | claimed |
| US-12409240-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | CURASIGHT A/S (DK) | 2025-09-09 | — | — | US | claimed |
| US-20250049971-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | CURASIGHT A/S (DK) | 2025-02-13 | — | — | US | claimed |
| WO-2024153756-A1 | RADIONUCLIDE LABELLED PEPTIDE CONJUGATE FOR SITE-SPECIFIC UPAR-TARGETING | CURASIGHT A/S (DK) | 2024-07-25 | — | — | WO | claimed |
| EP-3590542-B1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | CURASIGHT AS (DK) | 2024-01-03 | — | — | EP | claimed |
| EP-4197561-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | Curasight A/S (DK) | 2023-06-21 | — | — | EP | claimed |
| US-20220202966-A1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | CURASIGHT A/S (DK) | 2022-06-30 | — | — | US | claimed |
| US-11311637-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | CURASIGHT A/S (DK) | 2022-04-26 | — | — | US | claimed |
| EP-1621546-B1 | Peptide ligands specific to immonoglobulins | TECNOGEN SPA (IT) | 2008-10-29 | — | — | EP | claimed |
| US-7026282-B1 | Peptide antagonists of the human urokinase receptor and method for selecting them | Cancerforskningsfonden AF 1989 (Fonden Til Fremme AF Exsperimentel Cancerforskning) (DK) | 2006-04-11 | — | — | US | claimed |
| EP-1621546-A1 | Peptide ligands specific to immonoglobulins | TECNOGEN S.C.P.A. (IT) | 2006-02-01 | — | — | EP | claimed |
| WO-2000001802-A2 | PEPTIDE ANTAGONISTS OF THE HUMAN UROKINASE RECEPTOR AND METHOD FOR SELECTING THEM | CANCERFORSKNINGSFONDEN AF 1989 (FONDEN TIL FREMME AF EKSPERIMENTEL CANCERFORSKNING) (DK) | 2000-01-13 | — | — | WO | claimed |
| US-20260140060-A1 | COLORIMETRIC DETECTION OF A VIRAL INFECTION | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-05-21 | — | — | US | disclosed |
| US-20260124281-A1 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE | ENTERA BIO LTD. (IL) | 2026-05-07 | — | — | US | disclosed |
| WO-1994003483-A1 | ENDOTHELIN RECEPTOR-BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
| US-4904655-A | Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5] | ROUSSEL UCLAF (FR) | 1990-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589171-B2 | 177-Lu labeled peptide for site-specific uPAR-targeting | LNPEP, XPNPEP2, PLAUR | MC5R 1499/4885MC3R 600/4885MC1R 654/4885 |
| US-20220202966-A1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | PLAUR, PLAU, SERPINE1 | MC5R 1481/4885MC3R 899/4885MC1R 229/4885 |
| US-20260124281-A1 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE | PTH1R, FGF23, PTMS | MC5R 326/4885MC3R 167/4885MC1R 1028/4885 |
| US-12409240-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | PLAUR, PLAU, SERPINE1 | MC5R 1481/4885MC3R 899/4885MC1R 229/4885 |
| US-11311637-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | PLAUR, PLAU, SERPINE1 | MC5R 1481/4885MC3R 899/4885MC1R 229/4885 |
| US-20250049971-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | PLAUR, PLAU, PROKR1 | MC5R 95/4885MC3R 160/4885MC1R 64/4885 |
| US-20250319215-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCCS) | PLAUR, PLAU, SERPINE1 | MC5R 792/4885MC3R 712/4885MC1R 240/4885 |
| US-20260140060-A1 | COLORIMETRIC DETECTION OF A VIRAL INFECTION | CTSL, CPA4, ACE2 | MC5R 2348/4885MC3R 1653/4885MC1R 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.